Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.

NCT07288749 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1484

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM)
Chronic Heart Failure (CHF)

Interventions

DRUG: Glimepiride (oral)
DRUG: Placebo

Sponsor

Tongji Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]